J&J Must Pay Basilea $130M Over License: Dutch Court
A Dutch arbitration tribunal has ordered Johnson & Johnson to shell out $130 million to Basilea Pharmaceutica Ltd. for breaching its license agreement covering the experimental antibiotic ceftobiprole, the Switzerland-based Basilea...To view the full article, register now.
Already a subscriber? Click here to view full article